Optimization of a Meropenem-Tobramycin Combination Dosage Regimen against Hypermutable and Nonhypermutable Pseudomonas aeruginosa via Mechanism-Based Modeling and the Hollow-Fiber Infection Model [Pharmacology]

Landersdorfer, C. B., Rees, V. E., Yadav, R., Rogers, K. E., Kim, T. H., Bergen, P. J., Cheah, S.-E., Boyce, J. D., Peleg, A. Y., Oliver, A., Shin, B. S., Nation, R. L., Bulitta, J. B.
The American Society for Microbiology (ASM)
Published 2018